0AC9 Stock Overview
DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
DSM-Firmenich AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €107.35 |
| 52 Week High | €119.46 |
| 52 Week Low | €75.10 |
| Beta | 0 |
| 1 Month Change | 2.82% |
| 3 Month Change | 15.09% |
| 1 Year Change | -8.78% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -7.18% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0AC9 | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | 2.0% | 4.9% | 2.7% |
| 1Y | -8.8% | -32.3% | 5.2% |
Return vs Industry: 0AC9 exceeded the UK Chemicals industry which returned -32.3% over the past year.
Return vs Market: 0AC9 underperformed the UK Market which returned 5.2% over the past year.
Price Volatility
| 0AC9 volatility | |
|---|---|
| 0AC9 Average Weekly Movement | 4.7% |
| Chemicals Industry Average Movement | 7.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0AC9 has not had significant price volatility in the past 3 months.
Volatility Over Time: 0AC9's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1902 | 28,685 | Dimitri de Vreeze | www.dsm-firmenich.com |
DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. It operates through Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients.
DSM-Firmenich AG Fundamentals Summary
| 0AC9 fundamental statistics | |
|---|---|
| Market cap | €28.48b |
| Earnings (TTM) | -€658.00m |
| Revenue (TTM) | €10.63b |
2.7x
P/S Ratio-43.3x
P/E RatioIs 0AC9 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0AC9 income statement (TTM) | |
|---|---|
| Revenue | €10.63b |
| Cost of Revenue | €8.02b |
| Gross Profit | €2.61b |
| Other Expenses | €3.27b |
| Earnings | -€658.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Jul 30, 2024
| Earnings per share (EPS) | -2.48 |
| Gross Margin | 24.57% |
| Net Profit Margin | -6.19% |
| Debt/Equity Ratio | 19.2% |
How did 0AC9 perform over the long term?
See historical performance and comparison